Patient First
Always with Integrity
One Diverse Team
Dare to make a difference
To become a high-quality enterprise
that continues to contribute the value
of China's medical industry
Dare to make a difference

Click to watch

Research Fields
Providing Innovative and Effective Medications All Over the World and Put the Full Strength in the New Drug R&D
Strong R&D
Technological Capability
Data as of March 31, 2023
  • Employees worldwide
    Nearly 5000
  • R&D investment in 2022
    RMB 5.67 billion
(Refer to exchange rate of July 12, 2023:100JPY=5.16CNY)
  • Chinese patients benefited
    10+ million
Corporate Social Responsibilities
Continuously Creating and Contributing New
Value to Human Health and Happiness Based in China

We coordinate and cooperate with internal and external stakeholders; engage stakeholders in dialogues to maximize contribution to the society; positively consider the global environment when taking actions; enable community and regional development through corporate activities; insist on implementing social contribution activities in different fields such as education, environmental protection, and disaster relief; request employees to pay attention to the corporate social responsibility activities.

About Us
Practicing the Concept of Patient-centered
Care to Continuously Gain Trust from Society

We are composed of Sumitomo Pharma (Suzhou) Co., Ltd. and Sumitomo Pharmaceutical  (China) Co., Ltd.. Since its entry into the Chinese market in the 1990s,Sumitomo Pharma (Suzhou) Co., Ltd.has been making comprehensive efforts to advance the market for 26 years, considering China as an important global partner. Over the years, Sumitomo Pharma (Suzhou) Co., Ltd.has adhered to the concept of patient-oriented management. Its pharmaceutical products encompass the field of the central nervous system, infection prevention, and cardiovascular diseases.


Presently, we has branch offices in Shanghai, Beijing, and Guangzhou. A plant  in Suzhou was set up to ensure drug safety. Sumitomo Pharma (Suzhou) Co., Ltd.always silently takes active actions for China's social welfare. Since the launch of a program to assist poverty-stricken areas in 2009, we has been supporting charities in China for 14 years, supporting nearly 17 projects.


We pay attention to the mental health education and popularization of science for Chinese teenagers and continuously deliver lectures on the popularization of mental health knowledge among college students around the country. Moreover, we care about families suffering from mental illnesses, and support programs such as WABC and CAFF that can help these families establish platforms for communication with society. Meanwhile, Sumitomo Pharma (Suzhou) Co., Ltd.donated nearly RMB 3 million to China's fights against the pandemic and the floods in Henan Province. In the future, we will keep carrying out its corporate responsibilities in research fields related to people's livelihood. Sumitomo Pharma (Suzhou) Co., Ltd.will always stand behind China's medical industry. It will not only provide high-quality and accessible health solutions for Chinese patients but also actively introduce more new products and innovative means, thereby supporting Chinese patients and China's health sector, with a view of becoming a high-quality enterprise that makes continuous contributions to the development of China's medical industry.

Witness Our Development Together
Join Us
Join Sumitomo Pharma (Suzhou) Co., Ltd. to Contribute to the Development of China's Medical Industry, Improve Career Opportunities, Empower Personal Growth while Working

We sincerely invite you to follow and join Sumitomo Pharma (Suzhou) Co., Ltd. ceuticals. Let's make Sumitomo Pharma (Suzhou) Co., Ltd. ceuticals a high-quality enterprise that makes continuous contributions to the development of China's medical industry.

Copyright @2024 住友制药. All rights reserved  (沪)  -非经营性-2016-2024  沪ICP备16016494号-3   沪公网安备 31010102002939号
You are leaving the official website of
Sumitomo Pharma (Suzhou) Co., Ltd.

You are about to leave the official website of Sumitomo Pharma (Suzhou) Co., Ltd. and be redirected to a third-party website. Please be aware of the risks involved.